Philips North America LLC is recalling approximately 1,913,441 units of various IntelliVue patient monitors and measurement modules due to a technical issue that may prevent the devices from sounding alarms. The affected products include a wide range of MP and MX series monitors as well as Multi-Measurement modules. Philips has initiated this voluntary recall after discovering that these monitors might not alert medical staff during patient events.
The failure of a patient monitor to sound an alarm during a critical change in a patient's health status can lead to delayed medical intervention. This poses a significant risk of serious injury or death, as healthcare providers rely on these alarms to respond to life-threatening conditions.
Corrective action initiated by the firm.
Product Number: M8102A
Product Number: M8105A
Product Number: M8001A
Product Number: M8002A
Product Number: M8003A
Product Number: M8004A
Product Number: M8005A
Product Number: M8007A
Product Number: M8008A
Product Number: M8010A
Product Number: M3002A
Product Number: 867030
Product Number: 867033
Product Number: 866060
Product Number: 866062
Product Number: 866064
Product Number: 866066
Product Number: 865242
Product Number: 865241
Product Number: 866471
Product Number: 865240
Product Number: 866470
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.